When proteostasis goes bad: Protein aggregation in the cell

IUBMB Life

Volumn 69, Issue 2, 2017, Pages 49-54

  Radwan, Mona ^a   Wood, Rebecca J ^a   Sui, Xiaojing ^a   Hatters, Danny M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

amyloid; chaperones; protein aggregation; protein folding; protein misfolding; protein quality control; proteostasis

Indexed keywords

PROTEIN; PROTEOME;

CELLS; MEDICAL LITERATURE; PROTEIN AGGREGATION; PROTEIN HOMEOSTASIS; PROTEIN MISFOLDING; PROTEIN SYNTHESIS; REVIEW; CHEMISTRY; DEGENERATIVE DISEASE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEINOSIS;

HUMANS; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEOME;

EID: 85008496913     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1597     Document Type: Review

References (77)

1. Braselmann, E., and Clark, P. L. (2012) Autotransporters: the cellular environment reshapes a folding mechanism to promote protein transport. J. Phys. Chem. Lett. 3, 1063–1071.
2. Hutt, D. M., and Balch, W. E. (2013) Expanding proteostasis by membrane trafficking networks. Cold Spring Harb. Perspect. Biol. 5,
3. Calloni, G., Chen, T., Schermann Sonya, M., Chang, H-C., Genevaux, P., et al. (2012) DnaK functions as a central hub in the E. coli chaperone network. Cell Rep. 1, 251–264.
4. Szabo, A., Langer, T., Schröder, H., Flanagan, J., Bukau, B., et al. (1994) The ATP hydrolysis-dependent reaction cycle of the Escherichia coli Hsp70 system DnaK, DnaJ, and GrpE. Proc. Natl. Acad. Sci. USA 91, 10345–10349.
5. McCarty, J. S., Buchberger, A., Reinstein, J., and Bukau, B. (1995) The role of ATP in the functional cycle of the DnaK chaperone system. J. Mol. Biol. 249, 126–137.
6. Laufen, T., Mayer, M. P., Beisel, C., Klostermeier, D., Mogk, A., et al. (1999) Mechanism of regulation of Hsp70 chaperones by DnaJ cochaperones. Proc. Natl. Acad. Sci. USA 96, 5452–5457.
7. Westhoff, B., Chapple, J. P., van der Spuy, J., Höhfeld, J., and Cheetham, M. E. (2005) HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome. Curr. Biol. 15, 1058–1064.
8. Shalgi, R., Hurt, J. A., Krykbaeva, I., Taipale, M., Lindquist, S., and Burge, C. B. (2013) Widespread regulation of translation by elongation pausing in heat shock. Mol. Cell 49, 439–452.
9. Liu, B., Han, Y., and Qian, S. B. (2013) Cotranslational response to proteotoxic stress by elongation pausing of ribosomes. Mol. Cell 49, 453–463.
10. Brandman, O., Stewart-Ornstein, J., Wong, D., Larson, A., Williams, C. C., et al. (2012) A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151, 1042–1054.
11. Brandman, O., and Hegde, R. S. (2016) Ribosome-associated protein quality control. Nat. Struct. Mol. Biol. 23, 7–15.
12. Lykke-Andersen, J., and Bennett, E. J. (2014) Protecting the proteome: eukaryotic cotranslational quality control pathways. J. Cell. Biol. 204, 467–476.
13. Onuchic, J. N., and Wolynes, P. G. (2004) Theory of protein folding. Curr. Opin. Struct. Biol. 14, 70–75.
14. Anfinsen, C. B. (1973) Principles that govern the folding of protein chains. Science 181, 223–230.
15. Dinner, A. R., Sali, A., Smith, L. J., Dobson, C. M., and Karplus, M. (2000) Understanding protein folding via free-energy surfaces from theory and experiment. Trends Biochem. Sci. 25, 331–339.
16. Pace, C. N. (1986) Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol. 131, 266–280.
17. Burgess, N. K., Dao, T. P., Stanley, A. M., and Fleming, K. G. (2008) β-barrel proteins that reside in the Escherichia coli outer membrane in vivo demonstrate varied folding behavior in vitro. J. Biol. Chem. 283, 26748–26758.
18. Costello, S. M., Plummer, A. M., Fleming, P. J., and Fleming, K. G. (2016) Dynamic periplasmic chaperone reservoir facilitates biogenesis of outer membrane proteins. Proc. Natl. Acad. Sci. USA 113, E4794–E4800.
19. Wang, M., and Kaufman, R. J. (2016) Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature 529, 326–335.
20. Braselmann, E., Chaney, J. L., and Clark, P. L. (2013) Folding the proteome. Trends Biochem. Sci. 38, 337–344.
21. Jahn, T. R., and Radford, S. E. (2005) The Yin and Yang of protein folding. FEBS J. 272, 5962–5970.
22. Gidalevitz, T., Ben-Zvi, A., Ho, K. H., Brignull, H. R., and Morimoto, R. I. (2006) Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311, 1471–1474.
23. Ron, D., and Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell. Biol. 8, 519–529.
24. Skovronsky, D. M., Lee, V. M., and Trojanowski, J. Q. (2006) Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151–170.
25. David, D. C., Ollikainen, N., Trinidad, J. C., Cary, M. P., Burlingame, A. L., et al. (2010) Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol. 8, e1000450.
26. Brehme, M., Voisine, C., Rolland, T., Wachi, S., Soper James, H., et al. (2014) A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep. 9, 1135–1150.
27. Liang, V., Ullrich, M., Lam, H., Chew, Y., Banister, S., et al. (2014) Altered proteostasis in aging and heat shock response in C. elegans revealed by analysis of the global and de novo synthesized proteome. Cell. Mol. Life Sci. 71, 3339–3361.
28. Gidalevitz, T., Kikis, E. A., and Morimoto, R. I. (2010) A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr. Opin. Struct. Biol. 20, 23–32.
29. Gidalevitz, T., Krupinski, T., Garcia, S., and Morimoto, R. I. (2009) Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet. 5, e1000399.
30. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., et al. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507–511.
31. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486–489.
32. Kopito, R. R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell. Biol. 10, 524.
33. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant Huntingtin and the risk of neuronal death. Nature 431, 805–810.
34. Kaganovich, D., Kopito, R., and Frydman, J. (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454, 1088–1095.
35. Fändrich, M. (2012) Oligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity. J. Mol. Biol. 421, 427–440.
36. Ross, C. A., and Poirier, M. A. (2005) What is the role of protein aggregation in neurodegeneration?. Nat. Rev. Mol. Cell Biol. 6, 891–898.
37. Haass, C., and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid b-peptide. Nat. Rev. Mol. Cell Biol. 8, 101–112.
38. Woerner, A. C., Frottin, F., Hornburg, D., Feng, L. R., Meissner, F., et al. (2016) Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA. Science 351, 173–176.
39. Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., et al. (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525, 56–61.
40. Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., et al. (2015) GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129–133.
41. D'Angelo, M. A., Raices, M., Panowski, S. H., and Hetzer, M. W. (2009) Age-dependent deterioration of nuclear pore complexes causes a loss of nuclear integrity in postmitotic cells. Cell 136, 284–295.
42. Ramaswami, M., Taylor, J. P., and Parker, R. (2013) Altered ribostasis: RNA–protein granules in degenerative disorders. Cell 154, 727–736.
43. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668–1672.
44. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208–1211.
45. Kim, H. J., Kim, N. C., Wang, Y.-D., Scarborough, E. A., Moore, J., et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467–473.
46. Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A. P., et al. (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123–133.
47. Brangwynne, C. P., Eckmann, C. R., Courson, D. S., Rybarska, A., Hoege, C., et al. (2009) Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science 324, 1729–1732.
48. Kato, M., Han, T. W., Xie, S., Shi, K., Du, X., et al. (2012) Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149, 753–767.
49. Li, Y. R., King, O. D., Shorter, J., and Gitler, A. D. (2013) Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361–372.
50. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., et al. (1997) Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993.
51. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548.
52. von Hörsten, S., Schmitt, I., Nguyen, H. P., Holzmann, C., Schmidt, T., et al. (2003) Transgenic rat model of Huntington's disease. Hum. Mol. Genet. 12, 617–624.
53. Yang, S.-H., Cheng, P.-H., Banta, H., Piotrowska-Nitsche, K., Yang, J.-J., et al. (2008) Towards a transgenic model of Huntington/'s disease in a non-human primate. Nature 453, 921–924.
54. Johnston, J. A., Ward, C. L., and Kopito, R. R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell. Biol. 143, 1883–1898.
55. Polling, S., Mok, Y.-F., Ramdzan, Y. M., Turner, B. J., Yerbury, J. J., et al. (2014) Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell. J. Biol. Chem. 289, 6669–6680.
56. Polling, S., Ormsby, A. R., Wood, R. J., Lee, K., Shoubridge, C., et al. (2015) Polyalanine expansions drive a shift into alpha-helical clusters without amyloid-fibril formation. Nat. Struct. Mol. Biol. 22, 1008–1015.
57. Farrawell, N. E., Lambert-Smith, I. A., Warraich, S. T., Blair, I. P., Saunders, D. N., et al. (2015) Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 5, 13416.
58. O'Connell, J. D., Tsechansky, M., Royall, A., Boutz, D. R., Ellington, A. D., et al. (2014) A proteomic survey of widespread protein aggregation in yeast. Mol. Biosyst. 10, 851–861.
59. Wallace, E. W., Kear-Scott, J. L., Pilipenko, E. V., Schwartz, M. H., Laskowski, P. R., et al. (2015) Reversible, specific, active aggregates of endogenous proteins assemble upon heat stress. Cell 162, 1286–1298.
60. Walther, D. M., Kasturi, P., Zheng, M., Pinkert, S., Vecchi, G., et al. (2015) Widespread proteome remodeling and aggregation in aging C. elegans. Cell 161, 919–932.
61. Narayanaswamy, R., Levy, M., Tsechansky, M., Stovall, G. M., O'Connell, J. D., et al. (2009) Widespread reorganization of metabolic enzymes into reversible assemblies upon nutrient starvation. Proc. Natl. Acad. Sci. USA 106, 10147–10152.
62. Burkewitz, K., Choe, K., and Strange, K. (2011) Hypertonic stress induces rapid and widespread protein damage in C. elegans. Am. J. Physiol. Cell. Physiol. 301, C566–C576.
63. Weids, A. J., Ibstedt, S., Tamas, M. J., and Grant, C. M. (2016) Distinct stress conditions result in aggregation of proteins with similar properties. Sci. Rep. 6, 24554.
64. Ciryam, P., Tartaglia, G. G., Morimoto, R. I., Dobson, C. M., and Vendruscolo, M. (2013) Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep. 5, 781–790.
65. Silva, M. C., Fox, S., Beam, M., Thakkar, H., Amaral, M. D., et al. (2011) A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet. 7, e1002438.
66. Gupta, R., Kasturi, P., Bracher, A., Loew, C., Zheng, M., et al. (2011) Firefly luciferase mutants as sensors of proteome stress. Nat. Methods 8, 879 −884.
67. Jiang, L., Althoff, E. A., Clemente, F. R., Doyle, L., Röthlisberger, D., et al. (2008) De novo computational design of retro-aldol enzymes. Science 319, 1387–1391.
68. Liu, Y., Zhang, X., Chen, W., Tan, Y. L., and Kelly, J. W. (2015) Fluorescence turn-on folding sensor to monitor proteome stress in live cells. J. Am. Chem. Soc. 137, 11303–11311.
69. Liu, Y., Tan, Y. L., Zhang, X., Bhabha, G., Ekiert, D. C., et al. (2014) Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts. Proc. Natl. Acad. Sci. USA 111, 4449–4454.
70. Powers, E. T., Powers, D. L., and Gierasch, L. M. (2012) FoldEco: a model for proteostasis in E. coli. Cell Rep. 1, 265–276.
71. Cho, Y., Zhang, X., Pobre, K. F. R., Liu, Y., Powers, D. L., et al. (2015) Individual and collective contributions of chaperoning and degradation to protein homeostasis in E. coli. Cell Rep. 11, 321–333.
72. Balch, W. E., Morimoto, R. I., Dillin, A., and Kelly, J. W. (2008) Adapting proteostasis for disease intervention. Science 319, 916–919.
73. Parenti, G., Andria, G., and Valenzano, K. J. (2015) Pharmacological chaperone therapy: preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders. Mol. Ther. 23, 1138–1148.
74. Pedemonte, N., Lukacs, G. L., Du, K., Caci, E., Zegarra-Moran, O., et al. (2005) Small-molecule correctors of defective Delta F508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115, 2564–2571.
75. Lukacs, G. L., and Verkman, A. S. (2012) CFTR: folding, misfolding and correcting the ΔF508 conformational defect. Trends Mol. Med. 18, 81–91.
76. Waddington Cruz, M., Amass, L., Keohane, D., Schwartz, J., Li, H., et al. (2016) Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy. Amyloid 23, 178–183.
77. Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., et al. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427–434.